What is the NAV of ITI Pharma & Healthcare Fund?
The Current NAV of ITI Pharma & Healthcare Fund is ₹15.96, as of 20th June 2025What are the returns of ITI Pharma & Healthcare Fund?
The ITI Pharma & Healthcare Fund has been there since 8th November 2021- 1 Year Returns: 14.38
- 3 Year Returns: 23.81
What are the top 5 sectors holdings of ITI Pharma & Healthcare Fund?
The top sectors ITI Pharma & Healthcare Fund has invested in are as for 8th 11 2021 are as follows -- Pharmaceuticals | 73.61%
- Labs & Life Sciences Services | 20.25%
- Fertilizers & Agro Chemicals | 2.56%
- Others | 1.58%
- Oil & Gas - Refining & Marketing | 1.07%
What are the top 5 holdings ITI Pharma & Healthcare Fund?
The top 5 holdings for ITI Pharma & Healthcare Fund are- Sun Pharmaceutical Industries Ltd | 15.18%
- Divi's Laboratories Ltd | 9.12%
- Max Healthcare Institute Ltd | 5.42%
- Lupin Ltd | 5.40%
- Apollo Hospitals Enterprise Ltd | 5.19%
What is the asset allocation of ITI Pharma & Healthcare Fund?
The ITI Pharma & Healthcare Fund is a plan that invests- Equity | 99.71%
- Cash & Equivalents | 0.29%
How to invest in ITI Pharma & Healthcare Fund?
If you wish to invest in ITI Pharma & Healthcare Fund Plan via smallcase, you can follow these quick and easy steps -- Log in to smallcase
- Search and select the ITI Pharma & Healthcare Fund
- Complete filling your details and KYC
- Enter the Amount and type of investment (SIP or Lumpsum)
- And Voila! your SIP or Lumpsump investment in ITI Pharma & Healthcare Fund is completed
You can also calculate the returns on your investment based on our smallcase Lumpsum & SIP Calculator.
What is the AUM of ITI Pharma & Healthcare Fund?
The AUM of ITI Pharma & Healthcare Fund is 219.06 Cr as of 20th June 2025What is the expense ratio of ITI Pharma & Healthcare Fund Plan?
The expense ratio of ITI Pharma & Healthcare Fund Plan is 2.35How to exit ITI Pharma & Healthcare Fund?
If you have invested in ITI Pharma & Healthcare Fund, then simply visit your investment and you will find an option to exit the funds or invest more. Please click on 'exit' and add the amount or units. In case you want to exit from all units, you can simply click on the checkbox option shown.What is the alpha of ITI Pharma & Healthcare Fund?
The alpha ratio for the ITI Pharma & Healthcare Fund is 0.17
Alpha is the excess return of a fund compared to its expected return based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the Volatility or Standard Deviation of ITI Pharma & Healthcare Fund?
The volatility or standard deviation for the ITI Pharma & Healthcare Fund is 16.53
Standard Deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ITI Pharma & Healthcare Fund?
The sharpe ratio for the ITI Pharma & Healthcare Fund is 0.67
The Sharpe Ratio is a measure of risk-adjusted return that evaluates the performance of an investment, such as a mutual fund, by adjusting for its risk. Higher Sharpe Ratio, indicates a better risk-adjusted performance. A positive Sharpe Ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe Ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ITI Pharma & Healthcare Fund?
The Sortino ratio for the ITI Pharma & Healthcare Fund is 0.06
The Sortino ratio is a measure of risk-adjusted return for an investment, such as a mutual fund.
What is the Price to Earnings (PE) of ITI Pharma & Healthcare Fund?
The PE ratio (price-to-earnings) of the ITI Pharma & Healthcare Fund is 59.65 while category PE ratio is 53.461. Test MF FAQ for Mutual Fund ITI Pharma & Healthcare Fund Shares?
The Current NAV of ITI Pharma & Healthcare Fund is ₹15.96, as of 20th June 20255. Test MF FAQ Is there any lock-in period for ITI Pharma & Healthcare Fund Plan?
There is a lock in period of N/A for ITI Pharma & Healthcare Fund
Share
How to use scorecard? Learn more
ITI Pharma & Healthcare Fund Standard Growth
GrowthRegular
15.960.71% (+0.11)
High
—
—
Low
—
—
Returns
0.00%
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
1M
6M
1Y
3Y
5Y
Max
SIP
How to use scorecard? Learn more
ITI Pharma & Healthcare Fund Performance & Key Metrics
ITI Pharma & Healthcare Fund Performance & Key Metrics
| Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 2.35 | 59.65 | 0.67 |
| No LabelNo Label | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 1.49 | 53.46 | 0.59 |
ITI Pharma & Healthcare Fund Scheme InfoITI Pharma & Healthcare Fund Scheme Info
| PlanPlan | Lock inLock in | Exit LoadExit Load |
|---|---|---|
| Growth | 0 yrs | 0.50% |
| SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
|---|---|
| Allowed | ₹ 5,000 |
| BenchmarkBenchmark |
|---|
| Nifty Healthcare Index - TRI |
About Sector Funds - Pharma & Health Care
About Sector Funds - Pharma & Health Care
Sector Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
ITI Pharma & Healthcare Fund Portfolio
What are constituents?
What are constituents?
Mutual fund constituents are the various stocks, bonds, and other securities held within a fund. The size and mix of holdings depend on the category or type of fund. The holding analysis can give valuable understanding regarding the diversification of the fund.
ITI Pharma & Healthcare Fund Asset Allocation
ITI Pharma & Healthcare Fund Asset Allocation
Actual
Target
Sep 2024
Nov 2024
Mar 2025
May 2025
Sep 2024
Nov 2024
Mar 2025
May 2025
ITI Pharma & Healthcare Fund Sector Distribution
ITI Pharma & Healthcare Fund Sector Distribution
Sep 2024
Nov 2024
Mar 2025
May 2025
ITI Pharma & Healthcare Fund Sector Weightage
ITI Pharma & Healthcare Fund Sector Weightage
Pharmaceuticals
Pharmaceuticals as a % of total holdings for last six quarters
ITI Pharma & Healthcare Fund Current Holdings
ITI Pharma & Healthcare Fund Current Holdings
Equity
Others
- ConstituentHolding Weight3M Change
Holdings
15.18 %
-0.67 %Holdings
9.12 %
3.46 %Holdings
5.42 %
1.19 %
AMC Profile of ITI Pharma & Healthcare Fund
AMC Profile of ITI Pharma & Healthcare Fund
ITI Asset Management Holding Ltd. operates as a buy-side intermediation, advisory and asset management business in Emerging and Global Markets. It provides clients access to alternative investments, ETFs and other products of a different risk levels and investment horizons.
ITI Asset Management Holding Ltd. operates as a buy-side intermediation, advisory and asset management business in Emerging and Global Markets. It provides clients access to alternative investments, ETFs and other products of a different risk levels and investment horizons.
No.of Schemes
18
Total AUM
₹ 9,201.48 Cr.
ITI Pharma & Healthcare Fund Manager Details
ITI Pharma & Healthcare Fund Manager Details
ITI Pharma & Healthcare Fund Manager Profile
ITI Pharma & Healthcare Fund Manager Profile
Rohan Korde
AUM: ₹8,430.87 Cr.
|
Exp: —
Dhimant Shah
AUM: ₹7,559.48 Cr.
|
Exp: 18yrs
ITI Pharma & Healthcare Fund Manager Performance (0)
ITI Pharma & Healthcare Fund Manager Performance (0)
Equity: Sector Funds - Pharma & Health Care
ITI Pharma & Healthcare Fund Tax Implications
ITI Pharma & Healthcare Fund Tax Implications
Let’s calculate your returns after tax
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.
Historical
+
-
You make
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%